Case of recalcitrant amyopathic dermatomyositis treated with upadacitinib

Case of recalcitrant amyopathic dermatomyositis treated with upadacitinib

Saved in:

Bibliographic Details
Main Authors:	Albert E. Zhou, MD, PhD, Maria Katsetos, BS, Jun Lu, MD, PhD
Format:	Article
Language:	English
Published:	Elsevier 2024-12-01
Series:	JAAD Case Reports
Subjects:	autoimmune muscle diseases dermatomyositis DM immunopathology interferon signaling JAK inhibitors
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352512624003837
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Successful treatment of recalcitrant amyopathic dermatomyositis with deucravacitinib in addition to intravenous immunoglobulin
by: Megan E. McNamara, PhD, et al.
Published: (2025-08-01)

Dual immunomodulator therapy with adalimumab and upadacitinib to treat recalcitrant hidradenitis suppurativa
by: Zahidul Islam, BA, et al.
Published: (2025-02-01)

Treatment of recalcitrant hypertrophic lichen planus with upadacitinib
by: Sabrina F. Schundler, BS, et al.
Published: (2025-05-01)

Multisystemic Complications and Rapid Decline in Anti‐MDA‐5 Positive Amyopathic Dermatomyositis: A Case Study
by: Hem Prajapati, et al.
Published: (2025-03-01)

Amyopathic dermatomyositis with a rapidly progressing interstitial pneumonia
by: Darija Logvinova, et al.
Published: (2024-11-01)

Jaccoud arthropathy with anti-TIF1-γ-positive clinically amyopathic dermatomyositis: A rare association
by: Jiayi Zhang, MD, et al.
Published: (2025-05-01)

Efficacy and safety of oral upadacitinib-topical ruxolitinib combination therapy in the treatment of progressive nonsegmental vitiligo
by: Weiran Li, MD, et al.
Published: (2025-10-01)

Muscle Spatial Transcriptomic Reveals Heterogeneous Profiles in Juvenile Dermatomyositis and Persistence of Abnormal Signature After Remission
by: Margot Tragin, et al.
Published: (2025-06-01)

A pilot transcriptomic study of a novel multitargeted BRT regimen for anti–MDA5 antibody-positive dermatomyositis: improving survival over conventional therapy
by: Moe Tokunaga, et al.
Published: (2025-08-01)

Inflammatory breast cancer associated with amyopathic dermatomyositis: a case report
by: Gaku Inaguma, et al.
Published: (2020-11-01)

Successful Use of Upadacitinib, a Selective JAK Inhibitor, in the Treatment of Two Cases of Recalcitrant Chronic Uveitis
by: Diego Dominguez, et al.
Published: (2025-05-01)

Mycophenolate mofetil after tacrolimus for refractory clinically amyopathic dermatomyositis: a case report
by: Gui-Chen Ling, et al.
Published: (2024-10-01)

Diffuse erythema with “angel wings” sign in Belgian patients with antismall ubiquitin-like modifier activating enzyme antibody-associated dermatomyositis
by: Anne-Catherine Dens, MD, et al.
Published: (2025-06-01)

Anti-MDA-5 dermatomyositis with tumid lupus-like lesions
by: Kristiana Marie Jordan, BA, et al.
Published: (2025-06-01)

Case report: Successful treatment of anti‐MDA5‐positive to negative dermatomyositis‐associated interstitial lung disease with the JAK inhibitor tofacitinib
by: Zong Jiang, et al.
Published: (2023-06-01)

IFNλ is a potent anti‐influenza therapeutic without the inflammatory side effects of IFNα treatment
by: Sophia Davidson, et al.
Published: (2016-08-01)

Successful treatment of recalcitrant follicular lichen planus (lichen planopilaris) with the topical JAK 1/2 inhibitor ruxolitinib
by: Tanja Fetter, et al.
Published: (2025-03-01)

Oral lichen planus treated with upadacitinib: A case series
by: Christiaan H. Noot, BS, et al.
Published: (2025-09-01)

Anti–Melanoma Differentiation Associated Gene 5 (MDA 5) Dermatomyositis Complicated by Spontaneous Pneumomediastinum: A Case Report From South Africa
by: M. Myburgh
Published: (2024-11-01)

Altered microvasculature in patients with adult-onset dermatomyositis using optical coherence tomography angiography
by: Eliane Luisa Esser, et al.
Published: (2025-07-01)

Development and Evaluation of the Dermatomyositis Outcomes for Muscle and Skin as an Outcome Measure in Dermatomyositis Clinical Trials
by: Rachita Pandya, et al.
Published: (2025-03-01)

Dermatomyositis: A Multifaceted Autoimmune Connective Tissue Disorder: Series of Seven Cases
by: Mrunali Anil Joshi, et al.
Published: (2025-04-01)

Patients with overlapping dermatomyositis and psoriasis: an experience from a tertiary center and review of the literature
by: Beatriz Westphalen Pomianoski, et al.
Published: (2025-05-01)

Upadacitinib Monotherapy for Treatment of Pyoderma Gangrenosum
by: Mohamad R. Taha, et al.
Published: (2025-12-01)

Clinical characteristics and prognosis of amyopathic dermatomyositis patients with interstitial lung disease: insights from a retrospective cohort
by: Yanan Ying, et al.
Published: (2025-02-01)

Psoriasis in a patient with dermatomyositis
by: Pavlović Miloš D., et al.
Published: (2004-01-01)

Tofacitinib in Celiac Disease: Inducing Gluten Tolerance While Treating Psoriasis and Alopecia Areata
by: Anna Bowling, BS, et al.
Published: (2025-08-01)

IFN&alpha;/JAK/STAT1 Axis-Induced FBXO4 Modulates Muscle Cell Differentiation via &beta;-Catenin Degradation in Dermatomyositis
by: Yin L, et al.
Published: (2025-06-01)

Dermatomyositis following resection of thyroid and breast cancer: a case report and literature review
by: Miaomiao Yang, et al.
Published: (2025-01-01)

Pseudoangioedema as a presenting symptom of dermatomyositis with antinuclear matrix protein 2 autoantibodies
by: Han Li, MD, et al.
Published: (2025-04-01)

Treatment of eosinophilic annular erythema with upadacitinib
by: Wanyan Xiang, et al.
Published: (2025-12-01)

Spontaneous pneumomediastinum in dermatomyositis
by: Ankit Jain, et al.
Published: (2017-01-01)

Anti-interferon-α antibodies associate with disease activity and prognosis in anti-MDA5-positive dermatomyositis
by: Chao Sun, et al.
Published: (2025-07-01)

Bullous pemphigoid treated with baricitinib as steroid-sparing therapy for a patient with uncontrolled diabetes
by: Ji Won Heo, MD, et al.
Published: (2025-03-01)

Clinical observation of 10 cases of stable non-segmental vitiligo in adults treated with upadacitinib
by: Mingzhu Yuan, et al.
Published: (2025-12-01)

Successful treatment of an anti-MDA5 antibody-positive Juvenile Dermatomyositis patient with refractory interstitial lung disease using tofacitinib
by: Valentina Natoli, et al.
Published: (2025-02-01)

Case Report: Pembrolizumab in a patient with preexisting paraneoplastic dermatomyositis and sarcomatoid urothelial carcinoma. Searching for balance
by: Mariangela Torniai, et al.
Published: (2025-03-01)

Potential role of upadacitinib in cytomegalovirus colitis recurrence
by: Kaito Tsujinaka, et al.
Published: (2025-04-01)

Dysregulated type I/III interferon system in circulation from patients with anti-MDA5-positive dermatomyositis
by: Akira Yoshida, et al.
Published: (2025-07-01)

Upadacitinib for the treatment of radiographic axial spondyloarthritis — case series and review of the literature
by: Giuseppe Lopalco, et al.
Published: (2025-05-01)